Coronavirus antibody cocktail shortens recovery time, new data shows
New data on Regeneron's coronavirus monoclonal antibody cocktail shows the drug is "moving in the right direction," Stat News reports.
A high dose of the cocktail led viral levels to decrease more quickly in non-hospitalized patients. The drug also appeared to have a bigger effect in COVID-19 patients who had not created high levels of antibodies on their own, shortening their recovery time, even at a lower dose.
Regeneron's chief scientific officer George Yancopoulos said "we are highly encouraged by the robust and consistent nature of these initial data," adding that the company is discussing its findings with regulatory authorities while trials continue.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Non-affiliated observers like Eric Topol of the Scripps Research Translation Institute, meanwhile, told Stat that the data looks good so far, but "you just can't say much about how transformative this is going to be." Topol doesn't believe the treatment is ready for any sort of emergency authorization.
Still, the data comes on the heels of other promising results from Eli Lilly's monoclonal antibody candidate, adding to the hope that they could play a significant role in combating the virus. Read more at Stat News.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Kim Kardashian's Met Gala corset: designed for drama but a step too far?
In The Spotlight Reality TV star shocks with 'impossibly tiny waist' at this year's fashion event, echoing controversies from previous outfits
By Harriet Marsden, The Week UK Published
-
The Buddha of Suburbia: an 'orgiastic odyssey'
The Week Recommends Emma Rice brings Hanif Kureishi's 1990 novel to the stage
By The Week UK Published
-
'US tests ties with Israelis'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published